Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 120.50
+3.50 (2.99%)
Aug 1, 2025, 1:33 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 3.27 billion as of August 1, 2025. Its market cap has decreased by -22.26% in one year.
Market Cap
3.27B
Enterprise Value
3.31B
Revenue
2.12B
Ranking
n/a
PE Ratio
11.71
Stock Price
120.50
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.27B, an increase of 777.86%. That is a compound annual growth rate of 11.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.27B | -5.12% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | 2.93B | -8.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 191.55B |
| PharmaEssentia | 165.30B |
| Bora Pharmaceuticals Co., LTD. | 84.51B |
| Lotus Pharmaceutical | 57.32B |
| Oneness Biotech | 30.94B |
| Polaris Group | 28.04B |
| Center Laboratories | 26.57B |
| Pegavision | 24.53B |